Mimedx (MDXG) Shares Outstanding (Diluted Average) (2012 - 2026)

Mimedx has disclosed Shares Outstanding (Diluted Average) across 15 years of filings, most recently posting $148.4 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $148.4 million, down 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.4 million (down 0.82% YoY), and the FY2025 annual result was $149.7 million, changed 0.45% from the prior year.
• Shares Outstanding (Diluted Average) came in at $148.4 million for Q1 2026 at Mimedx, down from $149.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $150.0 million in Q1 2024 to a low of $111.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $149.0 million (2024), against an average of $136.5 million.
• Across the five-year window, Shares Outstanding (Diluted Average) jumped 32.02% in 2023 and decreased 0.82% in 2026, its largest moves.
• Mimedx's Shares Outstanding (Diluted Average) stood at $112.9 million in 2022, then climbed by 29.27% to $146.0 million in 2023, then advanced by 2.11% to $149.0 million in 2024, then advanced by 0.45% to $149.7 million in 2025, then dropped by 0.85% to $148.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $148.4 million (Q1 2026), $149.7 million (Q4 2025), and $149.6 million (Q3 2025), per Business Quant data.